Placebo nasal gel

DRUG4 trials

Sponsors

Destiny Pharma Plc, Repurposed Therapeutics, Inc., Bayer

Conditions

Motion SicknessMotion Sickness, SpaceNasal Congestion, Nasal ObstructionSea SicknessStaphylococcus Aureus Infection

Phase 1

Study of the Nasal Decolonisation of Staphylococcus Aureus (SA) and the Safety and Tolerability of XF-73 Nasal Gel in Healthy Subjects

CompletedNCT02282605

Destiny Pharma PlcStaphylococcus Aureus Infection

Start: 2014-09-30End: 2014-11-30Updated: 2016-10-07

Phase 2

Combination of Intranasal Scopolamine and Sensory Augmentation to Mitigate G-transition Induced Motion Sickness and Enhance Sensorimotor Performance

RecruitingNCT05886660

Repurposed Therapeutics, Inc.Motion Sickness, Motion Sickness, Space, Sea Sickness

Start: 2022-01-21End: 2024-09-30Target: 30Updated: 2024-05-17

A Study to Learn More About How Well Oxymetazoline HCl 0.05% Nasal Gel Works and How Safe It Is in Healthy Adults

CompletedNCT07582328

BayerNasal Congestion, Nasal Obstruction

Start: 2026-04-20End: 2026-05-28Updated: 2026-06-08

Phase 3

Prevention and Treatment of Nausea Associated With Motion Sickness in Senior Subjects

CompletedNCT03988530

Repurposed Therapeutics, Inc.Motion Sickness

Start: 2019-06-07End: 2020-11-23Updated: 2023-05-06